Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer

Aims: Vorinostat (suberoylanilide hydroxamic acid; SAHA) is a histone deacetylase inhibitor (HDACi) approved in the clinics for the treatment of T-cell lymphoma and with the potential to be effective also in breast cancer. We investigated the responsiveness to SAHA in human breast primary tumors and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antioxid Redox Signal
Main Authors: Chiaradonna, Ferdinando, Barozzi, Iros, Miccolo, Claudia, Bucci, Gabriele, Palorini, Roberta, Fornasari, Lorenzo, Botrugno, Oronza A., Pruneri, Giancarlo, Masullo, Michele, Passafaro, Alfonso, Galimberti, Viviana E., Fantin, Valeria R., Richon, Victoria M., Pece, Salvatore, Viale, Giuseppe, Di Fiore, Pier Paolo, Draetta, Giulio, Pelicci, Pier Giuseppe, Minucci, Saverio, Chiocca, Susanna
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2015
Assuntos:
Forum Original Research CommunicationsHistone Deacetylases (S. Chiocca, Ed.)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492673/
https://ncbi.nlm.nih.gov/pubmed/25897982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ars.2014.6189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados